Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-11 Sale | 2026-06-11 4:25 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 21,661 | $0 | $0 | 0 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:32 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 1,489 | $26.78 | $39,882 | 76,661 (Direct) | View |
| 2026-04-17 Sale | 2026-04-20 7:40 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 1,862 | $20.22 | $37,643 | 111,900 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:42 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 1,767 | $15.57 | $27,507 | 73,762 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 6:50 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 4,471 | $13.45 | $60,139 | 75,529 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-21 Exercise | 2026-05-26 7:32 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 5,000 | $0 | 76,661 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 6,250 | $0 | 111,900 (Direct) | View |
| 2026-02-21 Exercise | 2026-02-24 7:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 5,000 | $0 | 73,762 (Direct) | View |
| 2026-01-16 Option Award | 2026-01-21 4:10 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-26 6:50 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 15,000 | $0 | 75,529 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:35 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-09-09 Option Award | 2024-09-11 4:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 06:01 am | N/A 2034-02-01 | Elicio Therapeutics Inc. | ELTX | Piekos Brian Chief Financial Officer | 43,225 | $0 | 43,225 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:25 pm | N/A 2033-06-01 | Elicio Therapeutics Inc. | ELTX | Piekos Brian Chief Financial Officer | 75,484 | $0 | 75,484 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 7:14 pm | N/A N/A | Gemini Therapeutics Inc. | GMTX | Piekos Brian CFO | 9,960 | $1.09 | 17,615 (Direct) | View |
| 2022-01-13 Option Award | 2022-01-14 09:01 am | N/A N/A | Gemini Therapeutics Inc. | GMTX | Piekos Brian CFO | 280,876 | $0 | 280,876 (Direct) | View |
| 2021-10-18 Option Award | 2021-10-20 5:49 pm | N/A N/A | Gemini Therapeutics Inc. | GMTX | Piekos Brian Chief Financial Officer | 90,720 | $0 | 90,720 (Direct) | View |